MBRX · Moleculin Biotech, Inc. · Documents
$6.50
+0.61 (+10.36%)
At close · Oct 23
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 13, 2026
Substantial doubt about the company's ability to continue as a going concern.
“As of June 30, 2026, the Company had an accumulated deficit of $226.5 million since inception and had not yet generated any revenues from operations. Additionally, management anticipates that its cash on hand of $7.3 million as of June 30, 2026, is not sufficient to fund its planned operations for a period of at least one year from when these condensed consolidated financial statements are issued. These factors raise substantial doubt regarding the Company's ability to continue as a going concern.”View the 10-Q filed Aug 13, 2026
Market Cap
$6.33M
Shares
973,869
Volume · Oct 23
27.74K
Avg daily vol (4 sessions)
65.18K
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| 8-K | — | 2024-03-19 | — | |
| 8-K | — | 2024-02-29 | — | |
| 8-K | — | 2024-02-22 | — | |
| 8-K | — | 2024-02-15 | — | |
| 8-K | — | 2024-02-14 | — | |
| 8-K | — | 2024-02-14 | — | |
| S-1 | — | 2024-02-02 | — | |
| 8-K | — | 2024-01-24 | — | |
| DEF 14A | — | 2024-01-16 | 2024-02-14 | |
| PRE 14A | — | 2024-01-05 | 2024-02-14 | |
| 8-K | — | 2024-01-05 | 2023-12-29 | |
| 8-K | — | 2023-12-21 | 2023-12-20 | |
| 8-K | — | 2023-12-18 | — | |
| 8-K | — | 2023-12-11 | — | |
| 8-K | — | 2023-12-11 | — | |
| 8-K | — | 2023-11-20 | — | |
| 8-K | — | 2023-11-13 | — | |
| 8-K | — | 2023-11-13 | — | |
| 10-Q | — | 2023-11-13 | 2023-09-30 | |
| 8-K | — | 2023-11-13 | — | |
| 8-K | — | 2023-11-07 | — | |
| 8-K | — | 2023-11-06 | — | |
| 8-K | — | 2023-11-03 | 2023-11-02 | |
| 8-K | — | 2023-10-17 | — | |
| 8-K | — | 2023-10-06 | 2023-10-03 | |
| 8-K | — | 2023-10-02 | — | |
| 8-K | — | 2023-09-21 | — | |
| 8-K | — | 2023-09-18 | — | |
| 8-K | — | 2023-09-14 | — | |
| DEF 14A | — | 2023-09-01 | 2023-10-03 | |
| 8-K/A | — | 2023-08-23 | 2023-08-21 | |
| PRE 14A | — | 2023-08-21 | 2023-10-03 | |
| 8-K | — | 2023-08-21 | — | |
| 8-K | — | 2023-08-21 | 2023-08-18 | |
| 8-K | — | 2023-08-11 | — | |
| 10-Q | — | 2023-08-10 | 2023-06-30 | |
| 8-K | — | 2023-08-10 | — | |
| 8-K | — | 2023-08-07 | — | |
| 8-K | — | 2023-08-03 | — | |
| 8-K | — | 2023-07-13 | — | |
| 8-K/A | — | 2023-06-16 | 2023-05-25 | |
| 8-K | — | 2023-06-13 | — | |
| DEFA14A | — | 2023-06-07 | — | |
| DEFA14A | — | 2023-05-30 | — | |
| 8-K | — | 2023-05-26 | 2023-05-25 | |
| 8-K | — | 2023-05-12 | — | |
| DEFA14A | — | 2023-05-12 | — | |
| 8-K | — | 2023-05-11 | — | |
| 10-Q | — | 2023-05-10 | 2023-03-31 | |
| 8-K | — | 2023-05-10 | — |
Showing 201–250 of 407 filings